scholarly journals ESSENTIAL THROMBOCYTOSIS IN CHILDREN

2021 ◽  
Vol 43 ◽  
pp. S57
Author(s):  
Canan ALBAYRAK ◽  
Davut ALBAYRAK
2019 ◽  
Vol 31 (3) ◽  
pp. 143-147
Author(s):  
Cengiz CEYLAN ◽  
Murat AKŞİT ◽  
Mehmet Can UĞUR ◽  
Merve ZEYTİNLİ AKŞİT ◽  
Bilge TAŞKIRAN ◽  
...  

2021 ◽  
Vol 84/117 (4) ◽  
Author(s):  
Ertan Karacay ◽  
Utku Cenikli ◽  
Ahmet Özsimsek ◽  
Irem Atalay Karacay ◽  
Yavuz Yüksel ◽  
...  

Medicine ◽  
2019 ◽  
Vol 98 (26) ◽  
pp. e16203 ◽  
Author(s):  
Yang Yu ◽  
Xinyue Zhang ◽  
Qingyang Shi ◽  
Meiyan Wang ◽  
Jili Jing ◽  
...  

2019 ◽  
Vol 49 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Canan ALBAYRAK ◽  
Pınar TARKUN ◽  
Elif BİRTAŞ ATEŞOĞLU ◽  
Ceyla ERALDEMİR ◽  
Özgür Doğa ÖZSOY ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
L Wu ◽  
B Liu ◽  
Y Zheng

Abstract Background/Introduction Essential thrombocytosis (ET) is a rare disease characterized by vasomotor symptom, thrombotic event, and hemorrhage. Due to its rare occurrence, limited data are available to examine the impact of ET on acute myocardial infarction (AMI). Purpose To evaluate the impact of ET on hospital outcomes of AMI. Methods We use the 2016 National Inpatient sample database to identify all the admissions with a principal diagnosis of AMI with or without ET. A matched control group was then generated using propensity score from age, sex, race, location, insurance, income, hospital type, hospital location, Charlsoncat Comorbidity Score. Prevalence, baseline characteristic of AMI patient with or without ET was described and compared. Univariable logistic regression was used to measure mortality and the rate of catheterization. Results ET was found in 0.28% (1,814) in total AMI admissions (641,854). Age (69.52 vs 69.70), female percentage (48.04% vs 48.03%) and baseline comorbidities including STEMI (27.49% vs 25.08%), diabetes (33.03% vs 30.51%), heart failure (40.18 vs 45.89%) and chronic kidney disease (22.05% vs 26.28%) was found to be comparable between two groups (p>0.05, table 1). Compared to non ET group, ET is associated with significantly higher hospital mortality (5.74% vs 2.43%, OR 2.44 [1.09–5.48], p=0.03), prolonged length of stay (7.61 vs 4.30 days, p<0.01). Interestingly, ET is also associated with lower utilization of cardiac catheterization (37.46% vs 46.52%, p=0.01). Essential Thrombocytosis and AMI Parameter AMI with ET Matched control: AMI without ET Odds ratio (95% CI) P value (n=1,814) (n=1,814) Age, years 69.52±0.72 69.70±0.70 p>0.05 Female, % 48.04 48.03 p>0.05 STEMI, % 27.49 25.08 p>0.05 Hypertension, % 81.57 83.08 p>0.05 Diabetes, % 33.03 30.51 p>0.05 Heart failure, % 40.18 45.89 p>0.05 Chronic kidney disease, % 22.05 26.28 p>0.05 Mortality, % 5.74 2.43 2.44 (1.09–5.48) p=0.03 Catheterization, % 37.46 46.52 0.68 (0.51–0.91) P=0.01 Length of stay, days 7.61±0.48 4.30±0.21 P<0.01 Values are reported as mean ± S.E. Categorical variables are represented as frequency. Conclusion ET is infrequently observed in patients with AMI. Having ET is associated with higher hospital mortality, longer hospital stay and lower utilization of cardiac catheterization. Acknowledgement/Funding None


1986 ◽  
Vol 75 (3) ◽  
pp. 188-189 ◽  
Author(s):  
Alessandra Casonato ◽  
Fabrizio Fabris ◽  
Lucia Zancan ◽  
Antonio Girolami

2019 ◽  
Vol 110 (5) ◽  
pp. 584-590
Author(s):  
Makoto Yoshimitsu ◽  
Miho Hachiman ◽  
Yuichiro Uchida ◽  
Naosuke Arima ◽  
Akihiko Arai ◽  
...  

2003 ◽  
Vol 72 (2) ◽  
pp. 152-153 ◽  
Author(s):  
W.Y. Au ◽  
C.L. Liu ◽  
C.M. Lo ◽  
S.T. Fan ◽  
S.K. Ma

Sign in / Sign up

Export Citation Format

Share Document